• [1]
    Ghalioungui, P. (1979) Fermented beverages in antiquity. In: Fermented food beverages in nutrition (Gastineau, Clifford F., Darby, William J., Turner, Thomas B., Eds.), pp.3–19 Academic Press, London.
  • [2]
    Haller, D., Blum, S., Bode, C., Hammes, W.P., Schiffrin, E.J. (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect. Immun. 68, 752759.
  • [3]
    Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L., Hudault, S. (1997) The human Lactobacillus acidophilus strain La1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63, 27472753.
  • [4]
    Gotteland, M., Cruchet, S., Verbeke, S. (2001) Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment. Pharmacol. Ther. 15, 1117.
  • [5]
    Reid, G., Sanders, M.E., Gaskins, H.R., Gibson, G.R., Mercenier, A., Rastall, R., Roberfroid, M., Rowland, I., Cherbut, C., Klaenhammer, T.R. (2003) New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37, 105118.
  • [6]
    Kalliomaki, M., Isolauri, E. (2003) Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol. 3, 1520.
  • [7]
    Kanauchi, O., Mitsuyama, K., Araki, Y., Andoh, A. (2003) Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Des. 9, 333346.
  • [8]
    Hatakka, K., Martio, J., Korpela, M., Herranen, M., Poussa, T., Laasanen, T., Saxelin, M., Vapaatalo, H., Moilanen, E., Korpela, R. (2003) Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study. Scand. J. Rheumatol. 32, 211215.
  • [9]
    Tannock, G.W., Munro, K., Harmsen, H.J., Welling, G.W., Smart, J., Gopal, P.K. (2000) Analysis of the faecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66, 25782588.
  • [10]
    Pridmore, R.D., Berger, B., Desiere, F., Vilanova, D., Barretto, C., Pittet, A.C., Zwahlen, M.C., Rouvet, M., Altermann, E., Barrangou, R., Mollet, B., Mercenier, A., Klaenhammer, T., Arigoni, F., Schell, M.A. (2004) The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC533. Proc. Natl. Acad. Sci. USA 101, 25122517.
  • [11]
    Haller, D., Bode, C., Hammes, W.P., Pfeifer, A.M., Schiffrin, E.J., Blum, S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 7987.
  • [12]
    Ibnou-Zekri, N., Blum, S., Schiffrin, E.J., von der Weid, T. (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun. 71, 428436.
  • [13]
    Bernet, M.F., Brassart, D., Neeser, J.R., Servin, A.L. (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35, 483489.
  • [14]
    Neeser, J.R., Granato, D., Rouvet, M., Servin, A., Teneberg, S., Karlsson, K.A. (2000) Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 10, 11931199.
  • [15]
    Cruchet, S., Obregon, M.C., Salazar, G., Diaz, E., Gotteland, M. (2003) Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19, 716721.
  • [16]
    Gotteland, M., Cruchet, S. (2003) Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J. Antimicrob. Chemother. 51, 13171319.
  • [17]
    Bouhnik, Y., Pochart, P., Marteau, P., Arlet, G., Goderel, I., Rambaud, J.C. (1992) Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 102, 875878.
  • [18]
    Ventura, M., Zink, R. (2002) Specific identification and molecular typing analysis of Lactobacillus johnsonii by using PCR-based methods and pulsed-field gel electrophoresis. FEMS Microbiol. Lett. 217, 141154.
  • [19]
    Rigottier-Gois, L., Le Bourhis, A.G., Gramet, G., Rochet, V., Dore, J. (2003) Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol. Ecol. 43, 237245.
  • [20]
    Amann, R.I., Ludwig, W., Schleifer, K.H. (1995) Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59, 143169.
  • [21]
    Wallner, G., Amann, R., Beisker, W. (1993) Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14, 136143.
  • [22]
    Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., Schleifer, K.H. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 10971106.
  • [23]
    Langendijk, P.S., Schut, F., Jansen, G.J., Raangs, G.C., Kamphuis, G.R., Wilkinson, M.H., Welling, G.W. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl. Environ. Microbiol. 61, 30693075.
  • [24]
    Harmsen, H.J.M., Elfferich, P., Schut, F., Welling, G.W. (1999) A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization. Microbiol. Ecol. Health. Dis. 11, 312.
  • [25]
    Franks, A.H., Harmsen, H.J., Raangs, G.C., Jansen, G.J., Schut, F., Welling, G.W. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64, 33363345.
  • [26]
    Suau, A., Rochet, V., Sghir, A., Gramet, G., Brewaeys, S., Sutren, M., Rigottier-Gois, L., Dore, J. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst. Appl. Microbiol. 24, 139145.
  • [27]
    Harmsen, H.J., Wildeboer-Veloo, A.C., Grijpstra, J., Knol, J., Degener, J.E., Welling, G.W. (2000) Development of16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of coriobacteriaceae in human feces from volunteers of different age groups. Appl. Environ. Microbiol. 66, 45234527.
  • [28]
    Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A., Corthier, G. (2001) Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl. Environ. Microbiol. 67, 49394942.
  • [29]
    Gibson, G.R. (1999) Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J. Nutr. 129 (Suppl.), 1438S1441S.
  • [30]
    Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., Sato, S. (2003) Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52, 7983.
  • [31]
    Wensinck, F., Van de Merwe, J.P. (1981) Serum agglutinins to Eubacterium and Peptostreptococcus species in Crohn's and other diseases. J. Hyg. (Lond.) 87, 1324.